Podcasts

Diana Finkel, DO, director, Infectious Disease Fellowship Program, Rutgers New Jersey Medical School, discusses current issues in HIV care in the United States, including barriers to access for transgender patients, how COVID-19 impacted...

Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...

Peter Lio, MD, FAAD, clinical assistant professor of dermatology & pediatrics, Northwestern University Feinberg School of Medicine, and founding director, Chicago Integrative Eczema Center, discusses the common challenges associated with...

Jim Dean, MD, PhD, Imbruvica global development lead and executive medical director, AbbVie, discusses data from the RESONATE-2 study showing that single-agent ibrutinib (Imbruvica) improved progression-free and overall survival for up to...

Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...

According to Gil Melmed, MD, gastroenterologist, recurrent CDI is multifactorial, and when estimating the burden of this condition, both direct and indirect costs should be considered.

Gil Melmed, MD, gastroenterologist, reviews the burden linked with recurrent Clostridioides difficile (CDI), provides need-to-know information for payers to better inform formulary placement, and discusses the direct and indirect costs linked...

Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, discusses fundamental barriers within HIV care, and how the US health system can better manage the HIV epidemic, which...